Tamro Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tamro Group - overview
Location
Vantaa, -, Finland
Primary Industry
Pharmaceuticals
About
Tamro Group is a leading distributor of pharmaceuticals and health products, specializing in logistics and tailored services for healthcare stakeholders in Finland and across Europe. Tamro Group is dedicated to the distribution of pharmaceuticals and health products, headquartered in Vantaa, Finland. The company has evolved its operations to enhance supply chain efficiency. It has maintained a consistent focus on delivering reliable logistics to pharmacies and hospitals, adapting its strategies to meet the changing needs of the healthcare sector.
Tamro specializes in distributing pharmaceuticals and health products, providing logistics solutions that ensure timely and accurate delivery. Their comprehensive services include data-driven marketing assistance and digital solutions for home care, primarily catering to customers such as pharmacies, hospitals, and health product retailers across Finland and other European markets. In the fiscal year 2024, Tamro reported a revenue of USD 1,857. 80 mn and an EBITDA of USD 39.
83 mn, primarily derived from B2B transactions involving pharmacies and healthcare providers. Tamro Group plans to expand its product offerings and geographic reach. Future product launches are focused on enhancing logistics solutions and digital health services, expected to roll out in the next 12-18 months. The company aims to penetrate additional European markets to accommodate growing demand, facilitated by its recently secured funding, which will be directed towards these expansion initiatives.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.tamro.com
Total Amount Raised
Subscriber access only
Tamro Group - timeline of key events
Tamro Group - financials
| Fiscal Year Ended | Jan 31, 2010 | Jan 31, 2011 | Jan 31, 2012 | Jan 31, 2013 | Jan 31, 2014 | Jan 31, 2015 | Jan 31, 2016 | Jan 31, 2017 | Jan 31, 2018 | Jan 31, 2019 | Jan 31, 2020 | Jan 31, 2021 | Jan 31, 2022 | Jan 31, 2023 | Jan 31, 2024 | Jan 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 5,467,236,000 | 4,074,814,000 | 4,216,892,000 | 1,174,809,631.6 | 1,232,475,319 | 1,313,377,595 | 1,366,866,438.4 | 1,409,239,216.2 | 1,451,073,922 | 1,533,191,251.9 | 1,535,491,641.9 | 1,612,629,801.4 | 1,637,068,396.2 | - | - | - |
| % Revenue Growth (YoY) | - | (25.5%) | 3.5% | (72.1%) | 4.9% | 6.6% | 4.1% | 3.1% | 3.0% | 5.7% | 0.2% | 5.0% | 1.5% | - | - | - |
| EBITDA (USD) | 154,533,000 | 154,430,000 | 196,283,000 | 779,255,895.2 | 97,448,097.7 | 33,078,195.1 | 34,644,993.6 | 34,430,111.9 | 35,536,218.8 | 34,497,325.3 | 31,755,960.8 | 25,121,936.1 | 31,770,071.5 | - | - | - |
| Operating Income (USD) | 114,869,000 | 129,642,000 | 161,598,000 | 774,426,614 | 91,384,776.1 | 27,103,234.9 | 28,680,576 | 28,507,930.9 | 29,240,920.7 | 27,671,919.6 | 24,907,394.6 | 18,014,936.1 | 24,436,071.5 | - | - | - |
| Operating Margin | 2.1% | 3.2% | 3.8% | 65.9% | 7.4% | 2.1% | 2.1% | 2.0% | 2.0% | 1.8% | 1.6% | 1.1% | 1.5% | - | - | - |
| % EBITDA Margin | 2.8% | 3.8% | 4.7% | 66.3% | 7.9% | 2.5% | 2.5% | 2.4% | 2.4% | 2.3% | 2.1% | 1.6% | 1.9% | - | - | - |
| NET Income (USD) | 83,363,000 | 94,683,000 | 111,279,000 | 942,062,184.6 | 117,309,614.5 | 24,907,209.4 | 30,529,817 | 29,048,651.5 | 23,833,634.7 | 24,117,005 | 21,086,960.2 | 16,300,878.6 | 20,685,990.4 | - | - | - |
| % Net Margin | 1.5% | 2.3% | 2.6% | 80.2% | 9.5% | 1.9% | 2.2% | 2.1% | 1.6% | 1.6% | 1.4% | 1.0% | 1.3% | - | - | - |
Tamro Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Ada AB | - | ||||||||
| Buyout | Completed | OneMed Sverige AB | - |
Displaying 1 - 2 of 2
Tamro Group - employee data
Tamro Group - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board Of Directors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.